Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05635019 · ClinicalTrials.gov registry record · NA

FoodRx for Obesity Treatment

A NA study of Obesity and Food Insecurity, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
105
Enrollment target
1
Study location

NCT05635019: Completed NA study of Obesity and Food Insecurity, sponsored by University of Pennsylvania.

NCT05635019 is a NA study of Obesity and Food Insecurity that has completed, run by University of Pennsylvania. The registered enrollment target is 105 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05635019, a NA study of Obesity and Food Insecurity, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

This study is a 3-group, parallel design, randomized controlled trial (RCT) in 105 adults with obesity and food insecurity that will compare BWL-Alone (including standard-of-care referral and connection with community food resources; n=35) to BWL plus food supplementation with either food vouchers (BWL+VOUCHER; n=35) or home-delivered, medically tailored groceries consistent with BWL recommendations (BWL+HOME; n=35). All groups will have BWL treatment provided for 24 weeks per clinical guidelines. Food vouchers and HOME will be provided for 24 weeks of treatment. Assessments will be conducted at baseline, and weeks 12 and 24.

Primary Outcome

Comparison of BWL+VOUCHER and BWL+HOME vs BWL-Alone in weight change (percent of initial weight) at 24 weeks. Positive numbers represent increases and negative numbers represent decreases.

Conditions Studied

Interventions

  • BEHAVIORAL BWL+VOUCHER
  • BEHAVIORAL BWL+HOME
  • BEHAVIORAL Behavioral weight loss counseling (BWL)

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2022-12-01
Est. Completion 2024-07-01
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT05635019 record still lists

NCT05635019 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (87% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which BWL+VOUCHER is the first listed.

NCT05635019 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05635019 about?

NCT05635019 is a clinical study titled "FoodRx for Obesity Treatment". This study is a 3-group, parallel design, randomized controlled trial (RCT) in 105 adults with obesity and food insecurity that will compare BWL-Alone (including standard-of-care referral and connection with community food resources; n=35) to BWL plus food supplementation with either food vouchers (...

What is the current status of trial NCT05635019?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2022-12-01. Estimated completion is 2024-07-01.

What conditions does trial NCT05635019 study?

This clinical trial studies the following conditions: Obesity, Food Insecurity.

What interventions are being tested in trial NCT05635019?

The interventions under investigation include: BWL+VOUCHER (BEHAVIORAL), BWL+HOME (BEHAVIORAL), Behavioral weight loss counseling (BWL) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05635019?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05635019 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05635019's enrollment target sits among peer trials

105 465th of 1053 higher than 587 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05635019, the US trial registry maintained by the National Library of Medicine. NCT05635019 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.